Dexpramipexole: Clinical Trials

6 trials of Dexpramipexole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6

Follow Dexpramipexole: new trials by email Literature Review of Dexpramipexole trials Research Report on Dexpramipexole

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects
Dexpramipexole - Healthy Volunteers
Phase 1CompletedKnopp Biosciences242012-06-012014-11-25
Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study
Warfarin, Dexpramipexole - Healthy Volunteers
Phase 1CompletedKnopp Biosciences152012-05-012014-11-25
Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)
Dexpramipexole, Cimetidine plus Dexpramipexole - Amyotrophic Lateral Sclerosis
Phase 1CompletedKnopp Biosciences142012-03-012014-11-25
Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)
Dexpramipexole, Dexpramipexole Placebo, Moxifloxacin - Amyotrophic Lateral Sclerosis
Phase 1CompletedKnopp Biosciences682012-01-012014-11-25
Dexpramipexole SAD/MAD Study
Dexpramipexole, Dexpramipexole Placebo - Amyotrophic Lateral Sclerosis
Phase 1CompletedKnopp Biosciences632011-11-012014-11-25
Dexpramipexole Renal PK Study
Dexpramipexole (dose 1), Dexpramipexole (dose 2) - Amyotrophic Lateral Sclerosis, Renal Insufficiency
Phase 1CompletedKnopp Biosciences362011-07-012014-11-25

Conditions studied

Amyotrophic Lateral Sclerosis (4)  ·  Renal Insufficiency (1)

Sponsors

Knopp Biosciences (6)

Countries

United States (6)